Equillium, Inc. (EQ) — Stock Score Summary

Equillium, Inc. (EQ) has a MoatMap StockRank of 52/100 based on Quality (35/100), Value (37/100), and Momentum (66/100) factor scores. The current signal is HOLD. Equillium is a clinical-stage biotechnology company. It is highly speculative, pre-revenue, and lacks the quality compounding metrics (ROIC, cash flow) required by our investment philosophy.

Equillium, Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapies for severe autoimmune and inflammatory disorders. The company's lead product candidate, itolizumab, targets the CD6 signaling pathway to modulate T-cell activity, aiming to treat conditions such as acute graft-versus-host disease (aGVHD) and lupus nephritis. It operates as a specialized biotech firm, leveraging its deep understanding of immunology to address critical unmet needs in immune-mediated diseases.

Key Financial Metrics

Price$2.70
Market Cap$180M
P/E (Forward)-12.11
Price/Book3.37
Return on Equity-54.4%
Return on Invested Capital-81.6%
Debt/Equity1.16
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-13M

Equillium, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Equillium, Inc.’s (EQ) StockRank?
MoatMap’s StockRank for Equillium, Inc. (EQ) is 52/100, with a Hold signal. It is a composite of Quality (35), Value (37), and Momentum (66) factor ranks across MoatMap’s 19,000+ stock universe.
Does Equillium, Inc. have an economic moat?
Equillium, Inc. (EQ) has a Quality factor score of 35/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Equillium, Inc. a buy, hold, or sell?
MoatMap’s current signal for Equillium, Inc. (EQ) is Hold, based on a StockRank of 52/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Equillium, Inc. in?
Equillium, Inc. (EQ) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksEQ deep dive reportAI ChampionsHow we score stocksSense-check another stock